Pamplona Capital, which initially invested in Alvogen in 2014, maintains a minority stake. Pictured: Alvogen CEO Robert Wessman, left, Tomas Ekman, CVC partner, right
To read the entire story, you must be logged in.
Please log in now or register with us.
